Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae - PubMed (original) (raw)

Comparative Study

Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae

C D Steward et al. J Clin Microbiol. 1999 Mar.

Abstract

Fluoroquinolone resistance appears to be increasing in many species of bacteria, particularly in those causing nosocomial infections. However, the accuracy of some antimicrobial susceptibility testing methods for detecting fluoroquinolone resistance remains uncertain. Therefore, we compared the accuracy of the results of agar dilution, disk diffusion, MicroScan Walk Away Neg Combo 15 conventional panels, and Vitek GNS-F7 cards to the accuracy of the results of the broth microdilution reference method for detection of ciprofloxacin and ofloxacin resistance in 195 clinical isolates of the family Enterobacteriaceae collected from six U.S. hospitals for a national surveillance project (Project ICARE [Intensive Care Antimicrobial Resistance Epidemiology]). For ciprofloxacin, very major error rates were 0% (disk diffusion and MicroScan), 0.9% (agar dilution), and 2.7% (Vitek), while major error rates ranged from 0% (agar dilution) to 3.7% (MicroScan and Vitek). Minor error rates ranged from 12.3% (agar dilution) to 20.5% (MicroScan). For ofloxacin, no very major errors were observed, and major errors were noted only with MicroScan (3.7% major error rate). Minor error rates ranged from 8.2% (agar dilution) to 18.5% (Vitek). Minor errors for all methods were substantially reduced when results with MICs within +/-1 dilution of the broth microdilution reference MIC were excluded from analysis. However, the high number of minor errors by all test systems remains a concern.

PubMed Disclaimer

Cited by

Accuracy of six antimicrobial susceptibility methods for testing linezolid against staphylococci and enterococci.
Tenover FC, Williams PP, Stocker S, Thompson A, Clark LA, Limbago B, Carey RB, Poppe SM, Shinabarger D, McGowan JE Jr. Tenover FC, et al. J Clin Microbiol. 2007 Sep;45(9):2917-22. doi: 10.1128/JCM.00913-07. Epub 2007 Jul 18. J Clin Microbiol. 2007. PMID: 17634301 Free PMC article.
A prevalence and molecular characterization of novel pathogenic strains of Macrococcus caseolyticus isolated from external wounds of donkeys in Khartoum State -Sudan.
Ali DE, Allam M, Altayb HN, Mursi D, Adalla MA, Mohammed NO, Khaier MAM, Salih MH, Abusalab S, Abbas MA. Ali DE, et al. BMC Vet Res. 2022 May 25;18(1):197. doi: 10.1186/s12917-022-03297-2. BMC Vet Res. 2022. PMID: 35614464 Free PMC article.
Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.
Boyd LB, Atmar RL, Randall GL, Hamill RJ, Steffen D, Zechiedrich L. Boyd LB, et al. BMC Infect Dis. 2008 Jan 15;8:4. doi: 10.1186/1471-2334-8-4. BMC Infect Dis. 2008. PMID: 18197977 Free PMC article.
Evaluation of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of staphylococci and enterococci.
Carroll KC, Borek AP, Burger C, Glanz B, Bhally H, Henciak S, Flayhart DC. Carroll KC, et al. J Clin Microbiol. 2006 Jun;44(6):2072-7. doi: 10.1128/JCM.02636-05. J Clin Microbiol. 2006. PMID: 16757600 Free PMC article.
Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria.
Menozzi MG, Eigner U, Covan S, Rossi S, Somenzi P, Dettori G, Chezzi C, Fahr AM. Menozzi MG, et al. J Clin Microbiol. 2006 Nov;44(11):4085-94. doi: 10.1128/JCM.00614-06. Epub 2006 Sep 27. J Clin Microbiol. 2006. PMID: 17005752 Free PMC article.

References

1. Acar J F, Goldstein F W. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis. 1997;24(Suppl. 1):S67–S73. - PubMed
1. Andriole V T. Quinolones. In: Gorbach S L, Bartlett J G, Blackow N R, editors. Infectious diseases. W. B. Philadelphia, Pa: Saunders Company; 1998. pp. 283–285.
1. Blondeau J M, Yaschuk Y the Canadian Ciprofloxacin Study Group. Canadian ciprofloxacin susceptibility study: comparative study from 15 medical centers. Antimicrob Agents Chemother. 1996;40:1729–1732. - PMC - PubMed
1. Brenner D J, Farmer III J J, Fanning G R, Steigerwalt A G, Klykken P, Wathen H G, Hickman F W, Ewing W H. Deoxyribonucleic acid relatedness of Proteus and Providencia species. Int J Syst Bacteriol. 1978;28:269–282.
1. Cohen M A, Huband M D, Gage J W, Yoder S L, Roland G E, Gracheck S J. In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin. J Antimicrob Chemother. 1997;40:205–211. - PubMed

Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae - PubMed (original) (raw)